Haemonetics Corp (NYSE:HAE)

89.53
Delayed Data
As of Sep 29
 -1.63 / -1.79%
Today’s Change
72.26
Today|||52-Week Range
95.26
+13.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Operating ActivitiesNet Income / Starting Line-55.6M-26.3M45.6M55.0M
 
 
 
 
 
Depreciation89.9M89.7M89.2M109.4M
 
 
 
 
 
Total Other Cash Flow114.8M97.3M11.4M44.2M
 
 
 
 
 
Funds From Operations148.1M153.9M140.4M222.0M
 
 
 
 
 
Funds From/For Other Operating Expenses26.2M-5.8M-80.0M62.8M
 
 
 
 
 
Net Cash Flow - Operating Activities121.9M159.7M220.4M159.3M
 
 
 
 
 
 
InvestingCapital Expenditures-102.4M-76.1M-74.8M-119.0M
 
 
 
 
 
Fixed Asset Disposal637.0K2.8M11.8M2.8M
 
 
 
 
 
Other Investing - Uses-3.0M0.000.000.00
 
 
Net Cash Flow Investing-104.8M-73.3M-63.0M-116.1M
 
 
 
 
 
 
FinancingShort Term Borrowings2.3M-50.7M671.0K15.0M
 
 
 
 
 
Long Term Borrowings0.000.000.00347.8M
 
 
Long Term Debt Reduction-22.3M-42.7M-61.7M-266.9M
 
 
 
 
 
Net Proceeds Stock Sale18.4M33.0M40.3M13.4M
 
 
 
 
 
Common Preferred Redeemed-61.0M0.00-100.0M-160.0M
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-62.6M-60.4M-120.6M-50.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-12.0K-1.6M3.9M-3.3M
 
 
 
 
 
 
Net Change In Cash-45.5M26.0M36.7M-7.5M